NCT04367064

Brief Summary

This is an observational study for Corona virus disease by the Max Healthcare.Corona virus 2019 disease (COVID-19) is a respiratory tract infectious disease caused by a newly emergent corona virus. This virus is linked to the same family of viruses as Severe Acute Respiratory Syndrome (SARS) and some types of common cold.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 25, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 26, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 29, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2020

Completed
Last Updated

July 14, 2020

Status Verified

July 1, 2020

Enrollment Period

7 months

First QC Date

April 26, 2020

Last Update Submit

July 13, 2020

Conditions

COVID

Outcome Measures

Primary Outcomes (1)

  • we will compare the clinical outcome of the COVID 19 patients with their age and gender

    Collection of the baseline demographic details of the patient, along with medical history; current disease status; current and previous treatment details; and the results of all the laboratory tests performed, as per the standard clinical practices. All the data will be entered into Excel sheet, row wise for each patient. For studying the demographic profile, the age will be divided into standard 10-year intervals and percentages will be obtained for each sex and combined for males and females. This will be in addition to the mean and SD of age.

    3-4 months

Secondary Outcomes (1)

  • we will compare the effect of different treatments given to the COVID 19 patients at Max Hospital

    3-4 months

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All the confirmed cases of COVID 19 getting treated at Max Super Speciality Hospital (DDF) as per the standard treatment protocol and policy for COVID 19.

You may qualify if:

  • Patients of either sex aged ≥18 years
  • Patients who are Covid-19 positive
  • All patients with positive Corona virus infection admitted in the hospitals of Max Healthcare will be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation)

New Delhi, National Capital Territory of Delhi, 110017, India

RECRUITING

Study Officials

  • Sandeep Budhiraja, MRCP, FACP

    Max Healthcare

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sandeep Budhiraja, MRCP, FACP

CONTACT

9810262954sbudhiraja@maxhealthcare.com

Ram Shankar Mishra, DNB, FRCP

CONTACT

9810193145docmishra@yahoo.co.in

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2020

First Posted

April 29, 2020

Study Start

April 25, 2020

Primary Completion

November 25, 2020

Study Completion

December 25, 2020

Last Updated

July 14, 2020

Record last verified: 2020-07

Locations

IN(1)